Some prejudices about this condition negatively affect the quality of life of those affected

People affected by epilepsy have had to coexist historically with certain stigmas that have even linked them to diabolic or sacred events. Although much progress has been made in this regard in developed countries, there are still many prejudices regarding this condition and it is proven that the social consequences of epilepsy can be very serious. One of the main struggles of those affected by epilepsy and their environment on a daily basis is not the condition itself and the significant physical damage it can cause, but the fight against epilepsy as a social condition that produces anxiety, depression and isolation among the affected.

Epilepsy is a global condition, regardless of borders, race or language ​​and affects 1 in 100 people according to WHO (although recent studies raise that percentage considerably). But depending on the culture, education and access to information of the affected person’s environment, there is a significant variation in the quality of life of the person suffering from epilepsy. Stigma and exclusion are present around the condition in both developed and developing countries.

The media, films and television series tend to portray epilepsy as a mental illness (which it is not). It is common for epileptic seizures to be portrayed as emergencies related to convulsion; in some cases, epilepsy is also linked to violent attitudes. In the media, little is explained about what the condition really is, its consequences and how to treat an affected person if necessary. Platforms such as Epilepsy Action, Epilepsy Society or the recent Seize Your Adventure work to normalize the condition socially with real and contrasted information, but until our whole society has access to real and contrasted information, the fight against epilepsy as a social condition will not be won.

The stigmas about epilepsy can cause:

  • Social isolation
  • Depression
  • Anxiety (and consequently, predisposition to seizures)
  • Insecurity
  • Difficulty finding a job
  • Difficulty having relationships in adolescence

Not everything is in the hands of science and technology…. You too can fight for a better understanding of epilepsy by spreading the word.

MJN Neuroserveis works to fight epilepsy in all aspects it affects by developing technologies that redefine the current paradigm on the prediction of epileptic seizures, such as SERAS_Epilepsy, as well as actively collaborating on projects such as Epieduca for the inclusion and intervention of the condition in the classroom with the Apoyodravet Foundation, and supporting patients through awareness campaigns through its communication channels.

Leave a Reply

El usuario que cumplimenta la información requerida en el presente formulario declara estar legitimado para ello y se hace responsable exclusivo de la veracidad e integridad de los datos e información que introduce, exonerando expresamente a MJN NEUROSERVEIS de cualquier responsabilidad que pudiera generarse para esta entidad con ocasión de la información facilitada a través del presente formulario.

Sí, acepto

Save the date

The next Saturday 21st of November at 4 pm, you will be able to know first hand our product: mjn-SERAS.
mjn-SERAS is a healthcare product that sends a warning signal when the risk of epileptic seizures is high, to the affected person and their trusted contacts.

Sign up now!


    mjn-SERAS is a medical device with CE marking according to the European Directive 93/42/EEC and the Royal Decree RD. 1591/2009.
    Contraindications: Do not use the product if you suffer from an infection in the ear canal or if you suffer from a skin lesion in the vicinity of the product's area of influence.
    Considerations: This medical product works with an APP only on Android phones. The results tested are 96% sensitivity and 94% specificity.
    CPSP20103CAT.

    Save the date

    El próximo sábado 21 de noviembre a las 4 de la tarde, podrás conocer de primera mano nuestro producto: mjn-SERAS.
    mjn-SERAS es un producto sanitario que lanza una señal de aviso cuando el riesgo de crisis de epilepsia es elevado, a la persona afectada y a sus contactos de confianza.

    ¡Inscríbete!

      mjn-SERAS es un producto sanitario con marcado CE conforme a la Directiva Europea 93/42/EEC y el Real Decreto RD. 1591/2009.
      Contraindicaciones: No usar el producto en caso de padecer una infección en el canal auditivo o en caso de padecer una lesión cutánea en las proximidades del área de influencia del producto.
      Consideraciones: Este producto sanitario funciona con una APP solo en teléfonos Android. Los resultados testeados son 96% de sensibilidad y 94% de especificidad.
      CPSP20103CAT.